Target type: biologicalprocess
The chemical reactions and pathways involving phosphatidylethanolamine, any of a class of glycerophospholipids in which a phosphatidyl group is esterified to the hydroxyl group of ethanolamine. It is a major structural phospholipid in mammalian systems. It tends to be more abundant than phosphatidylcholine in the internal membranes of the cell and is an abundant component of prokaryotic membranes. [GOC:curators, ISBN:0198506732]
Phosphatidylethanolamine (PE) metabolic process is a complex and essential pathway in all living organisms. PE is a major phospholipid component of cell membranes and plays critical roles in membrane structure, signal transduction, and cellular trafficking. This process encompasses a variety of enzymatic reactions that synthesize, modify, degrade, and interconvert PE molecules.
**Biosynthesis:**
* **De novo synthesis:** The primary pathway for PE biosynthesis involves the condensation of CDP-ethanolamine with diacylglycerol catalyzed by phosphatidylethanolamine synthase. This reaction is highly regulated and influenced by factors such as substrate availability and the presence of specific enzymes.
* **Decarboxylation of phosphatidylserine (PS):** Another significant pathway for PE biosynthesis involves the decarboxylation of PS by phosphatidylserine decarboxylase. This reaction is particularly important in eukaryotes, where PS is a precursor for PE.
**Modification and Interconversion:**
* **Methylation:** PE can be methylated to form phosphatidylcholine (PC), another major phospholipid. This methylation process is catalyzed by a series of enzymes called phosphatidylethanolamine N-methyltransferases.
* **Acyl exchange:** The fatty acid composition of PE can be modified through acyl exchange reactions, where specific fatty acids are removed and replaced with others. This process is critical for regulating membrane fluidity and function.
**Degradation:**
* **Hydrolysis:** PE can be hydrolyzed by phospholipases, which cleave the phosphodiester bond between the diacylglycerol and ethanolamine head group. This degradation pathway releases free ethanolamine and diacylglycerol, which can be used for other metabolic processes.
**Function:**
* **Membrane structure:** PE is a major component of cell membranes, contributing to their structural integrity and fluidity. It interacts with other lipids and proteins to form complex membrane domains with specific functions.
* **Signal transduction:** PE plays a role in signal transduction pathways by interacting with specific proteins and enzymes. For example, PE can act as a substrate for phospholipases that generate second messengers involved in cellular signaling.
* **Cellular trafficking:** PE is involved in the transport of proteins and lipids within cells. It can act as a carrier molecule for specific cargo and participate in the formation of transport vesicles.
**Regulation:**
The phosphatidylethanolamine metabolic process is tightly regulated to ensure proper cellular function. This regulation involves:
* **Enzyme activity:** The activity of key enzymes involved in PE metabolism is regulated by various factors, including substrate availability, product accumulation, and signaling pathways.
* **Gene expression:** The expression of genes encoding enzymes involved in PE metabolism is regulated by cellular needs and environmental cues.
* **Membrane dynamics:** The distribution and composition of PE in cellular membranes is dynamically regulated to ensure optimal function and maintain membrane integrity.
In summary, the phosphatidylethanolamine metabolic process is an essential pathway in all living organisms that plays critical roles in membrane structure, signal transduction, and cellular trafficking. It is a highly regulated process that involves a variety of enzymatic reactions that synthesize, modify, degrade, and interconvert PE molecules.'"
Protein | Definition | Taxonomy |
---|---|---|
Group IID secretory phospholipase A2 | A group IID secretory phospholipase A2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9UNK4] | Homo sapiens (human) |
Group 3 secretory phospholipase A2 | A group 3 secretory phospholipase A2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9NZ20] | Homo sapiens (human) |
Phospholipase A2, membrane associated | A phospholipase A2, membrane associated that is encoded in the genome of human. [PRO:DNx, UniProtKB:P14555] | Homo sapiens (human) |
Group 10 secretory phospholipase A2 | A group 10 secretory phospholipase A2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:O15496] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
quinacrine | quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9. Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2. | acridines; aromatic ether; organochlorine compound; tertiary amino compound | antimalarial; EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor |
nifedipine | Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure. | C-nitro compound; dihydropyridine; methyl ester | calcium channel blocker; human metabolite; tocolytic agent; vasodilator agent |
ubenimex | ubenimex: growth inhibitor | ||
5-benzyloxytryptophan | |||
fpl 67047xx | FPL 67047XX: inhibits phospholipase A2; structure in first source | ||
3-octylthio-1,1,1-trifluoro-2-propanone | 3-octylthio-1,1,1-trifluoro-2-propanone: a pesticide synergist; inhibits juvenile hormone esterase | ||
varespladib | aromatic ether; benzenes; dicarboxylic acid monoamide; indoles; monocarboxylic acid; primary carboxamide | anti-inflammatory drug; antidote; EC 3.1.1.4 (phospholipase A2) inhibitor | |
ly 311727 | LY 311727: a potent & selective inhibitor of human non-pancreatic secretory phospholipase A2; structure given in first source | ||
amentoflavone | biflavonoid; hydroxyflavone; ring assembly | angiogenesis inhibitor; antiviral agent; cathepsin B inhibitor; P450 inhibitor; plant metabolite | |
ochnaflavone | ochnaflavone : A biflavonoid with an ether linkage between the B-rings of the apigenin and luteolin subunits. It has been isolated from several members of the Ochnaceae plant family. ochnaflavone: from Lonicera japonica; structure given in first source | aromatic ether; biflavonoid; hydroxyflavone | anti-inflammatory agent; antiatherogenic agent; antibacterial agent; EC 3.1.1.4 (phospholipase A2) inhibitor; leukotriene antagonist; plant metabolite |
manoalide | manoalide : A sesterterpenoid isolated from the marine sponge Luffariella variabilis and which has been shown to exhibit inhibitory activity towards phospholipase A2. manoalide: phospholipase A2 inhibitor; sesterterpene from marine sponge L. variabilis; structure given in first source | butenolide; lactol; sesterterpenoid | EC 3.1.1.4 (phospholipase A2) inhibitor; EC 5.99.1.2 (DNA topoisomerase) inhibitor; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; metabolite |
ym 26734 | YM 26734: inhibits group II phospholipase A2; structure given in first source | ||
indoxam | indoxam: structure in first source | ||
bolinaquinone | bolinaquinone: a marine sesquiterpenoid from sponge Dysidea sp. with anti-inflammatory activity; structure in first source | ||
cacospongionolide b | cacospongionolide B: isolated from the sponge Fasciospongia cavernosa; structure in first source |